MoveDMD Trial: Catabasis Provides Update (February 2017) The Catabasis team spoke to our community on February 2, 2017 to discuss what they learned from this latest trial and what comes next in the MoveDMD program. Research & Clinical Trial Webinars,Webinars 8 years ago You may also like Webinar: Edgewise Therapeutics – Update on Sevasemten Program in Becker and Duchenne Muscular Dystrophies 2 weeks ago Research & Clinical Trial Webinars,Webinars edgewise,sevasemten Webinar: Sarepta Therapeutics – Safety Update on ELEVIDYS in Non-Ambulatory Individuals Living with Duchenne 3 weeks ago Research & Clinical Trial Webinars,Webinars elevidys,gene therapy,sarepta 1:14:53 Webinar: Dyne Therapeutics — The Clinical Impact of the FORCE™ Platform for Duchenne 1 month ago Research & Clinical Trial Webinars,Webinars dyne therapeutics,DYNE-251 59:44 Webinar: Steroids and Stress Dosing – Understanding the Updated PJ Nicholoff Steroid Protocol 1 month ago Care Webinars,Webinars emergency care,PJ's Protocol,steroids 01:06:15 Webinar: Discover the Power of Your Data – The Duchenne Registry 2 months ago Webinars The Duchenne Registry 1:20:43 Webinar: Sarepta Therapeutics – Duchenne Gene Therapy Update 3 months ago Research & Clinical Trial Webinars,Webinars elevidys,gene therapy,sarepta 29:52 Webinar: Duchenne Newborn Screening – Next Steps Following ACHDNC Dissolution 3 months ago Webinars newborn screening 59:32 Webinar: Wave Life Sciences – Update on FORWARD-53 Study of WVE-N531 3 months ago Research & Clinical Trial Webinars,Webinars wave life sciences,WVE-N531 123…27»Page 1 of 27